Winthrop Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7K Hold
19
﹤0.01% 247
2025
Q4
$6K Buy
+19
New +$6.03K ﹤0.01% 250
2025
Q3
Sell
-409
Closed -$114K 336
2025
Q2
$114K Buy
+409
New +$116K 0.03% 147
2025
Q1
Sell
-1,147
Closed -$297K 332
2024
Q4
$297K Buy
1,147
+160
+16% +$47.5K 0.08% 114
2024
Q3
$318K Sell
987
-13
-1% -$4.25K 0.15% 54
2024
Q2
$312K Buy
+1,000
New +$294K 0.16% 51

Other funds holding AMGN

Winthrop Capital Management's AMGN Position: Q1 2026 in Review

Winthrop Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 19 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #247.

Winthrop Capital Management first reported a position in AMGN in Q2 2024 and has held it in 6 quarters since. The position peaked at $318K in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Winthrop Capital Management held 19 shares of Amgen worth $7K as of Q1 2026.
  • Winthrop Capital Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up ﹤0.01% of Winthrop Capital Management's portfolio in Q1 2026, its #247 holding.
  • Winthrop Capital Management first reported a position in Amgen in Q2 2024 and has held it in 6 quarters since.
  • Winthrop Capital Management's Amgen position peaked at $318K in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.